In a 44-year-old female with bipolar disorder who has taken naproxen for several days and now has a serum creatinine of 1.06 mg/dL and a urine microalbumin-to-creatinine ratio of 186 mg/g, what management steps should be taken?

Immediate Management: Discontinue Naproxen

Stop naproxen immediately—NSAIDs are a well-established cause of acute kidney injury and can worsen albuminuria, particularly with short-term use in at-risk patients 1, 2. The combination of elevated creatinine (1.06 mg/dL) and microalbuminuria (UACR 186 mg/g, which exceeds the 30 mg/g threshold for increased cardiovascular and renal risk) suggests NSAID-induced renal injury 3.

Why Naproxen Must Be Stopped

NSAIDs like naproxen cause acute renal dysfunction through multiple mechanisms:

• Hemodynamic effects: NSAIDs inhibit prostaglandin synthesis, reducing renal blood flow and glomerular filtration, particularly in volume-depleted states 1
• Direct tubular toxicity: Can cause interstitial nephritis and tubular dysfunction 4
• Potentiation of injury: The FDA label explicitly warns that NSAIDs can precipitate acute kidney injury, especially with concomitant conditions 2

The guideline evidence is clear: ACE inhibitors and ARBs predispose to NSAID-induced acute renal failure, and NSAID administration during renal stress "will either potentiate or independently initiate an ARF episode" 1. While this patient isn't on ACE inhibitors, the principle of NSAID nephrotoxicity applies universally.

Assess for Volume Depletion and Medication Interactions

Evaluate for:

• Volume status: Dehydration, diuretic use, or recent illness with vomiting/diarrhea
• Bipolar medications: Lithium (which naproxen increases levels of, creating additional renal risk) 5
• Other nephrotoxic agents: Any ACE inhibitors, ARBs, or diuretics that weren't mentioned but may be present

The creatinine of 1.06 mg/dL represents a modest elevation for a 44-year-old woman (normal ~0.6-0.9 mg/dL), suggesting approximately 30-40% reduction in GFR—this falls within the "tolerable" range for medication-induced changes per KDIGO guidelines, but only if the offending agent is removed 6.

Monitor Renal Function Recovery

After stopping naproxen:

• Recheck creatinine and UACR in 3-7 days: NSAID-induced acute kidney injury typically reverses within 2-3 days if recognized before tubular damage occurs 1
• Expected pattern: Creatinine should decline toward baseline; if it continues rising or plateaus elevated, consider renal biopsy to evaluate for interstitial nephritis 4
• Watch for persistent albuminuria: If UACR remains ≥30 mg/g after renal function normalizes, this indicates underlying glomerular disease requiring ACE inhibitor or ARB therapy 6, 3

Research shows that even in patients with pre-existing mild renal impairment, naproxen 375 mg twice daily caused transient creatinine elevations, particularly with dose escalation 7. Your patient's "few days" of use likely caused reversible hemodynamic changes.

Address the Microalbuminuria

The UACR of 186 mg/g (normal <30 mg/g) is concerning and requires follow-up:

• If albuminuria persists after stopping naproxen: Initiate ACE inhibitor or ARB therapy titrated to maximum tolerated dose, as this reduces cardiovascular and renal events when UACR ≥30 mg/g 6, 3
• Target UACR reduction: Aim for ≥30% reduction from baseline, which correlates with decreased cardiovascular and kidney disease progression 3
• Blood pressure control: Target systolic BP <120 mmHg using standardized measurement 6

Critical caveat: Do NOT start ACE inhibitors or ARBs until renal function stabilizes and you confirm the patient doesn't have acute tubular injury or volume depletion, as these agents can worsen acute kidney injury in the setting of renal hypoperfusion 1, 6.

Alternative Pain Management

For her pain (reason for naproxen use):

• Acetaminophen: First-line alternative, no renal toxicity at therapeutic doses
• Topical NSAIDs: If localized musculoskeletal pain, minimal systemic absorption
• Non-pharmacologic: Physical therapy, heat/ice, depending on pain etiology

Avoid all systemic NSAIDs indefinitely if renal function doesn't fully recover or if she requires ACE inhibitor/ARB therapy for persistent albuminuria.

Common Pitfalls to Avoid

1. Don't assume the creatinine elevation is "mild" and continue NSAIDs: Even small increases represent significant GFR loss due to the hyperbolic relationship between creatinine and clearance 1
2. Don't start ACE inhibitors prematurely: Wait for renal recovery; starting them during acute injury risks worsening azotemia 1, 6
3. Don't ignore the albuminuria: UACR 186 mg/g predicts cardiovascular events and requires long-term management even if creatinine normalizes 3
4. Don't restart NSAIDs: This patient has demonstrated susceptibility to NSAID nephrotoxicity 2